Reasons for lack of appropriate receipt of primary Pneumocystis jiroveci pneumonia prophylaxis among HIV-infected persons receiving treatment in the United States:: 1994-2003

被引：15

作者：

Teshale, Eyasu H. ^{[1
]}

Hanson, Debra L. ^{[1
]}

Wolfe, Mitchell I. ^{[1
]}

Brooks, John T. ^{[1
]}

Kaplan, Jonathan E. ^{[1
]}

Bort, Zuleika ^{[1
]}

Sullivan, Patrick S. ^{[1
]}

机构：

[1] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV Sexually Transmitted Dis & TB Preven, Atlanta, GA 30333 USA

来源：

CLINICAL INFECTIOUS DISEASES | 2007年 / 44卷 / 06期

关键词：

D O I：

10.1086/511862

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：879 / 883

页数：5

共 13 条

[1] A RANDOMIZED TRIAL OF 3 ANTIPNEUMOCYSTIS AGENTS IN PATIENTS WITH ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION [J].

BOZZETTE, SA ;

FINKELSTEIN, DM ;

SPECTOR, SA ;

FRAME, P ;

POWDERLY, WG ;

HE, WL ;

PHILLIPS, L ;

CRAVEN, D ;

VANDERHORST, C ;

FEINBERG, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (11) :693-699

[2]

*CDCP, 1989, MMWR-MORBID MORTAL W, V5, P1

[3] SPECTRUM OF DISEASE IN PERSONS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION IN THE UNITED-STATES [J].

FARIZO, KM ;

BUEHLER, JW ;

CHAMBERLAND, ME ;

WHYTE, BM ;

FROELICHER, ES ;

HOPKINS, SG ;

REED, CM ;

MOKOTOFF, ED ;

COHN, DL ;

TROXLER, S ;

PHELPS, AF ;

BERKELMAN, RL .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 267 (13) :1798-1805

[4] SAFETY AND EFFICACY OF SULFAMETHOXAZOLE AND TRIMETHOPRIM CHEMOPROPHYLAXIS FOR PNEUMOCYSTIS-CARINII PNEUMONIA IN AIDS [J].

FISCHL, MA ;

DICKINSON, GM ;

LAVOIE, L .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1988, 259 (08) :1185-1189

[5] Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy [J].

Furrer, H ;

Egger, M ;

Opravil, M ;

Bernasconi, E ;

Hirschel, B ;

Battegay, M ;

Telenti, A ;

Vernazza, PL ;

Rickenbach, M ;

Flepp, M ;

Malinverni, R .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (17) :1301-1306

[6]

HAY JW, 1988, J ACQ IMMUN DEF SYND, V1, P466

[7] Epidemiology of human immunodeficiency virus-associated opportunistic infect-ions in the United States in the era of highly active antiretroviral therapy [J].

Kaplan, JE ;

Hanson, D ;

Dworkin, MS ;

Frederick, T ;

Bertolli, J ;

Lindegren, ML ;

Holmberg, S ;

Jones, JL .

CLINICAL INFECTIOUS DISEASES, 2000, 30 :S5-S14

[8] USPHS/IDSA GUIDELINES FOR THE PREVENTION OF OPPORTUNISTIC INFECTIONS IN PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS - AN OVERVIEW [J].

KAPLAN, JE ;

MASUR, H ;

HOLMES, KK ;

WILFERT, CM ;

SPERLING, R ;

BAKER, SA ;

TRAPNELL, CB ;

FREEDBERG, KA ;

COTTON, D ;

POWDERLY, WG ;

JAFFE, HW ;

LANIER, D ;

SCHRAM, N ;

COOPER, E ;

MAYER, K ;

BLINKHORN, R ;

ELLNER, J ;

ANGULO, J ;

BERKELMAN, R ;

BREIMAN, R ;

BRYAN, R ;

BEUHLER, J ;

CALDWELL, B ;

CASTRO, K ;

CHILDS, JE ;

CHU, S ;

CIESIELSKI, C ;

DROTMAN, DP ;

EDLIN, B ;

ELLERBROCK, T ;

FLEMING, P ;

GEITER, L ;

HAJJEH, R ;

HANSON, D ;

HOLMBERG, S ;

HUGHES, J ;

JAFFE, H ;

JONES, J ;

JURANEK, D ;

KELLER, D ;

MARTONE, W ;

MCNEIL, MM ;

MILLER, B ;

NAVIN, T ;

NESLUND, V ;

OSTROFF, S ;

PELLETT, PE ;

PINNER, R ;

REEF, S ;

REEVES, WC .

CLINICAL INFECTIOUS DISEASES, 1995, 21 :S12-S31

[9] Discontinuation of prophylaxis for Pneumocystis carinii pneumonia in HIV-1-infected patients treated with highly active antiretroviral therapy [J].

Schneider, MME ;

Borleffs, JCC ;

Stolk, RP ;

Jaspers, CAJJ ;

Hoepelman, AIM .

LANCET, 1999, 353 (9148) :201-203

[10]

United States. Department of Health and Human Services, 2000, HLTH PEOPL 2010 UND

← 1 2 →